UROMONITOR is transforming bladder cancer monitoring with a highly precise, non-invasive liquid biopsy approach.

Using a urine-based test, it detects highly sensitive and specific biomarkers associated with non-muscle-invasive bladder cancer (NMIBC), delivering accurate and reliable results. This offers an effective solution for recurrence detection in patients under routine surveillance.

With fast and dependable real-time PCR results, UROMONITOR serves as an alternative or complement to current standard-of-care (SOC) methods. In addition to significantly improving patients' quality of life by avoiding invasive procedures, it helps reduce the economic burden of NMIBC follow-up.

Our mission is to provide a simpler, more accessible solution that makes a meaningful impact for both patients and healthcare professionals, raising the standard of care in bladder cancer monitoring.

Uromonitor

Org chart

Teams

Offices